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Abstract
RIG-I and MDA5 are cytoplasmic sensors that recognize different species of viral RNAs, leads to activation of the
transcription factors IRF3 and NF-kB, which collaborate to induce type I interferons. In this study, we identified REUL, a RING-
finger protein, as a specific RIG-I-interacting protein. REUL was associated with RIG-I, but not MDA5, through its PRY and
SPRY domains. Overexpression of REUL potently potentiated RIG-I-, but not MDA5-mediated downstream signalling and
antiviral activity. In contrast, the RING domain deletion mutant of REUL suppressed Sendai virus (SV)-induced, but not
cytoplasmic polyI:C-induced activation of IFN-b promoter. Knockdown of endogenous REUL by RNAi inhibited SV-triggered
IFN-b expression, and also increased VSV replication. Full-length RIG-I, but not the CARD domain deletion mutant of RIG-I,
underwent ubiquitination induced by REUL. The Lys 154, 164, and 172 residues of the RIG-I CARD domain were critical for
efficient REUL-mediated ubiquitination, as well as the ability of RIG-I to induce activation of IFN-b promoter. These findings
suggest that REUL is an E3 ubiquitin ligase of RIG-I and specifically stimulates RIG-I-mediated innate antiviral activity.
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Introduction
The innate immune system plays critical roles in recognizing
viral infections, and triggers signaling cascades that induce anti-
viral mediators such as type I interferons (IFNs) and pro-
inflammatory cytokines [1]. Type I IFNs induce the expression
of a set of IFN-stimulated genes that inhibit viral replication in
infected cells as well as in neighboring uninfected cells.
Transcriptional activation of the promoters of type I IFN genes
requires the coordinated activation of multiple transcription
factors and their cooperative assembly into transcriptional
enhancer complexes in vivo. The enhancer of the IFN-b gene
contains a kB site recognized by nuclear factor kB (NF-kB), a site
for ATF-2/c-Jun, and two IFN-stimulated response elements
(ISREs) recognized by phosphorylated interferon regulatory factor
(IRF)-3 and/or IRF-7 [2].
The innate immune system has evolved at least two distinct
mechanisms for the recognition of viral RNAs [1]. One is
mediated by membrane-bound Toll-like receptors, which are
important for the production of type I IFNs in plasmacytoid
dendritic cells (pDCs). The second mechanism involves cytosolic
receptors for RNAs, retinoic-acid-inducible gene-I (RIG-I) and
melanoma differentiation associated protein-5 (MDA5), which
play essential roles in the recognition of RNA viruses in various
cells other than pDCs. Gene-knockout studies indicate that RIG-I
and MDA5 are required for responding to distinct species of RNA
viruses. RIG-I responds to in vitro-transcribed dsRNA, vesicular
stomatitis virus (VSV), Newcastle disease virus (NDV), and
influenza virus in mice. In contrast, MDA5 recognizes poly(I:C)
and is essential for the antiviral response to the picornavirus
encephalomyocarditis virus [3,4]. Furthermore, RIG-I, but not
MDA5, recognizes single-strand RNA bearing 59 phosphate [5,6].
Both RIG-I and MDA5 belong to the DExD/H box RNA
helicase family, and contain two CARD modules at their N
terminus and a DexD/H-box helicase domain at their C terminus.
The helicase domains of RIG-I and MDA5 serve as intracellular
viral RNA receptors, whereas the CARD modules are responsible
for transmitting signals to the downstream CARD-containing
adaptor VISA/MAVS/IPS-1/Cardif, which in turn activates
TAK1-IKKa and TBK1/IKKb kinases, leading to activation of
NF-kB and IRF-3 and induction of type I IFNs [7–12].
As with other cytokine systems, several mechanisms are thought
to underlie the positive and negative regulation of RIG-I signaling.
It has recently become clear that RIG-I is regulated by ubiquitin
conjugation mediated by a RING finger family protein, RNF125,
an E3-ubiquitin ligase that specifies its proteosomal degradation
[13]. Expression of RNF125 increases (Lys)-48-linked polyubiqui-
tin and destabilization of RIG-I, while the exact locus for
RNF125-mediated RIG-I ubiquitination is not known. Recent
studies have shown that polyubiquitination of signaling proteins
through lysine (Lys)-63-linked polyubiquitin chains plays an
important role in the activation of NF-kB [14], while it was also
shown that RIG-I undergoes (Lys)-63-linked ubiquitination at its
N-terminal 2CARD. The Lys 172 residue of RIG-I is critical for
efficient ubiquitination and for VISA binding, as well as the ability
of RIG-I to induce antiviral signal transduction. And the K63-
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ligase [15].
In the present study, we identified a RING-finger protein,
REUL, as a novel RIG-I E3 ubiquitin ligase. REUL was
specifically associated with RIG-I through its PRY and SPRY
domains, and this interaction effectively resulted in a marked
increase of RIG-I downstream signaling activity. Furthermore, the
Lys 154, 164, and 172 residues of the RIG-I CARD domain were
determined to be critical for efficient REUL-mediated ubiquitina-
tion and for the ability of RIG-I to induce antiviral signal
transduction. These findings suggest that REUL is an E3 ubiquitin
ligase of RIG-I and specifically stimulates RIG-I-mediated innate
antiviral signaling.
Results
Identification of REUL
It is well established that RIG-I is an essential cytosolic sensor
for the innate immune response to certain viruses. However, the
regulatory mechanism of RIG-I-mediated signaling has not been
adequately characterized. To identify potential proteins that
interact with RIG-I and regulate its signaling, we performed yeast
two-hybrid screens of a human fetal kidney cDNA library using
full-length RIG-I as bait. From 5610
6 independent screened
clones, we identified 17 b-galactosidase-positive clones, among
which 5 clones encoded the C-terminal regions of RNF135 (Aa
125–432, GenBank accession number NM_032322.3, and also
identified as Riplet in recent publication [16]). This gene is located
in a chromosomal region known to be frequently deleted in
patients with neurofibromatosis [17–19]. On the basis of its
functions described below, we designated this protein as REUL
(for RIG-I E3 ubiquitin ligase). Since the REUL clone obtained
from the yeast two-hybrid screening was not full-length, we
amplified full-length REUL cDNA from the human fetal kidney
cDNA library using PCR. Human REUL contains 432 amino acid
residues and shares 57% sequence identity at the amino acid level
with its mouse ortholog (Fig. 1A). Structural analysis with several
programs indicated that REUL contains an N terminus RING-
finger domain, and a C terminus PRY and SPRY domain
(Fig. 1A). The middle region of REUL has no detectable similarity
to any other proteins.
To confirm whether REUL is expressed in mammalian cells at
the protein level, we raised a mouse antiserum against human
REUL. Western blot analysis showed that REUL was expressed as
a 48 kDa protein in all examined human cell lines, including
HEK293, HT1080, Hela, U937, K562, and HUVEC cells. The
size of the endogenous REUL protein was slightly smaller than
that of FLAG-tagged REUL overexpressed in HEK293 cells
(Fig. 1B). These data suggest that REUL is expressed at the protein
level.
We next determined the cellular localization of REUL.
Immunofluorescence experiments showed that overexpressed
and endogenous REUL were localized in the cytoplasm of
HEK293T and Hela cells (Fig. 1C).
Interaction between RIG-I and REUL
Because REUL interacted with RIG-I in the yeast two-hybrid
system, we further determined whether full-length REUL
interacted with RIG-I in mammalian cells. Coimmunoprecipita-
tion experiments in HEK293T cells principally indicated that
Flag-tagged RIG-I associated with HA-tagged REUL in co-
transfection experiments (Fig. 2A). This interaction was specific
because in the same experiment REUL did not interact with
MDA5, which is structurally and functionally related to RIG-I.
REUL also did not interact with adaptor protein VISA (Fig. 2A).
REUL was subsequently shown to colocalize with RIG-I in co-
transfected HEK293T and Hela cells (Fig. 2B). Double immuno-
fluorescent staining showed that overexpressed REUL had a
similar distribution pattern and overlapped with RIG-I, but not
VISA.
We next determined whether REUL interacts with RIG-I in
untransfected cells and the effects of viral infection on the
interaction. Endogenous coimmunoprecipitation experiments
indicated that RIG-I did not interact with REUL without
stimulation, but was associated with REUL after SV infection.
As a control, REUL did not interact with RIG-I under transfected
polyI:C stimulation (Fig. 2C). These results suggest that REUL is
associated with RIG-I in a viral-infection-dependent manner.
REUL contains an N-terminal RING-finger domain, and C-
terminal PRY and SPRY domains (Fig. 2D). To determine which
domain facilitated interaction with RIG-I, we made REUL
deletion mutants. Coimmunoprecipitation assays showed that the
mutants carrying PRY and SPRY domains (91–432 and 215–432)
bound to RIG-I as effectively as full-length REUL, whereas the
RING-finger domain mutant (1–90), the middle region mutant
(91–214) and the mutant carrying the RING-finger and the middle
region (1–214) did not interact with RIG-I (Fig. 2D). These results
suggest that the PRY and SPRY domains of REUL are required
for interaction with RIG-I.
RIG-I contains two CARD modules at the N terminus and a
DexD/H-box helicase domain at the C terminus. Similarly, we
made RIG-I deletion mutants and determined which domain is
required for interaction with REUL. Domain-mapping experi-
ments indicated that the mutant carrying the N terminal CARD
domain (1–218) and the mutant carrying the DexD/H-box
helicase domain (219–925) interacted with REUL individually
(Fig. 2E). Since REUL has similar domain structure with
TRIM25, we also detected the interactions between TRIM25
and RIG-I truncations for comparison. Coimmunoprecipitation
experiments demonstrated that, in the same way, TRIM25
interacted with the helicase domain of RIG-I as efficiently as
CARD domain of RIG-I. As control, in the same conditions the
RIG-I full length and truncated RIG-I did not interact with
TRIM5-a, which has a similar structure to TRIM25 and REUL
(Fig. 2E). These results suggest that there are multiple binding sites
on RIG-I which mediate the interaction with REUL and
TRIM25.
REUL potentiates RIG-I signaling
Because REUL is specifically associated with RIG-I, we
examined whether REUL is involved in regulation of RIG-I-
mediated signaling. In reporter assays, overexpression of REUL
alone had no apparent effect on activation of ISRE, NF-kB and
IFN-b promoter, while in cotransfection experiments, RIG-I-
mediated induction of ISRE, NF-kB and IFN-b promoter activity
considerably increased with REUL expression in a dose-
dependent manner (Fig. 3A, B, C). In these assays, REUL did
not increase MDA5-mediated activation of ISRE, NF-kB and
IFN-b promoter (Fig. 3A, B, C).
Dimerization and translocation are hallmarks of IRF3 activa-
tion. Consistently, overexpression of REUL potentiated RIG-I-
but not MDA5-mediated dimerization of IRF-3 (Fig. 3D). Double
immunofluorescence staining showed that overexpression of
REUL caused translocation of IRF3 into the nucleus in
HEK293 cells stably expressing RIG-I as efficiently as overex-
pression of VISA, but this did not happen in HEK293 cells stably
expressing MDA5 (Fig. 3E).
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antiviral and pro-inflammatory gene expression. In RT-PCR
experiments, we found that cotransfection of REUL potently
increased RIG-I-, but not MDA5-induced expression of endoge-
nous antiviral and pro-inflammatory genes, including IFN-b,
regulated on activation, normal T-cell expressed and secreted
(RANTES), interferon-stimulated gene 15 (ISG15) and TNFa
(Fig. 3F). These data suggest that REUL specifically increases
RIG-I- but not MDA5-mediated signaling.
Notably, we found that expression of the RING domain
deletion mutant REULDRING (Aa 91–432), which was sufficient
to bind to RIG-I, markedly suppressed RIG-I-, but not MDA5-
Figure 1. Sequence and expression of REUL. (A) Alignment of human and mouse REUL amino acid sequences. The RING, PRY and SPRY domains
are indicated by green, blue and red lines individually. (B) Expression of REUL in mammalian cells. Lysates of the indicated cells were analyzed by
Western blot with a mouse polyclonal anti-REUL antibody. (C) REUL localization in HEK293 and Hela cells. Upper panels: HEK293 cells transfected with
an expression plasmid for HA-tagged REUL, immunofluorescent staining was performed with anti-HA (aHA) or mouse IgG; untransfected HEK293 cells
stained with preimmune serum (preserum) or anti-REUL serum (aREUL); lower panels: transfected or untransfected Hela cells stained as in the upper
panels. The experiments were repeated twice, and similar results were obtained.
doi:10.1371/journal.pone.0005760.g001
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PLoS ONE | www.plosone.org 3 June 2009 | Volume 4 | Issue 6 | e5760Figure 2. REUL associates with RIG-I. (A) REUL interacts with RIG-I but not MDA5 and VISA. HEK293 cells (1610
6) were transfected with HA-REUL
alone or together with Flag-RIG-I, Flag-MDA5 and Flag-VISA plasmids (5 mg each). Cell lysates were immunoprecipitated (IP) with anti-Flag (aF), anti-
HA (aHA) or mouse IgG antibody (IgG). The immunoprecipitates were analyzed by Western blot (IB) with anti-HA or anti-Flag antibody. Whole-cell
lysates (WCL) were analyzed by Western blots with anti-HA and anti-Flag to determine the expression of REUL, RIG-I, MDA5 and VISA. (B) REUL is
colocalized with RIG-I but not VISA in HEK293T and Hela cells. Upper panels: HEK293T cells were transfected with HA-REUL, Flag-RIG-I or Flag-VISA.
Immunofluorescent staining was performed with anti-HA (red) and anti-Flag (green); lower panels: Hela cells were transfected and stained as in the
Novel E3/Stimulator of RIG-I
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manner (Fig. 3G, H, I). These data suggest that the RING domain
of REUL is required for its function to potentiate RIG-I-mediated
signaling.
Role of REUL in RIG-I antiviral activity
Previously, it has been demonstrated that RIG-I responds to
infection by SV, VSV, NDV, and influenza virus, whereas MDA5
is involved in IFN signaling triggered by poly (I:C) transfected into
the cytoplasm [3,19].We further determined whether REUL
played a role in the cellular antiviral response mediated by RIG-I.
In reporter gene assays, overexpression of REULDRING (Aa 91–
432) markedly inhibited SV-induced activation of ISRE, NF-kB
and IFN-b promoter in a dose-dependent manner (Fig. 4A, B, C).
In contrast, overexpression of REULDRING had no apparent
effect on IFN-b promoter activation triggered by cytoplasmic poly
(I:C) in HEK293T cells (Fig. 4D). These results confirmed that
REUL is positively and specifically involved in RIG-I-, but not
MDA5-mediated antiviral activity.
We next determined whether endogenous REUL is required for
RIG-I-mediated antiviral activity. We utilized three REUL-RNAi
plasmids targeting different sites of human REUL mRNA.
Transient transfection and Western blot analysis showed that
two of these RNAi plasmids (2# and 3#) markedly inhibited the
expression of transfected REUL in HEK293T cells, whereas the
1# RNAi plasmid had little effect on REUL expression (Fig. 4E).
In reporter gene assays, knockdown of REUL by 2# and 3#
suppressed SV-induced activation of ISRE, NF-kB and IFN-b
promoter as efficiently as VISA RNAi plasmid, whereas the 1#
had no apparent effect on SV-induced signaling (Fig. 4F, G, H).
Consistent with this, we found that transfection of REUL RNAi
plasmids 2# and 3# potently inhibited SV-induced expression of
endogenous IFN-b and RANTES in RT-PCR experiments
(Fig. 4I).
We further determined whether REUL plays a role in the
cellular antiviral response. On infection by newcastle disease virus
-enhanced green fluorescent protein (NDV-eGFP), REUL expres-
sion significantly suppressed NDV-eGFP replication in HEK293
cells, whereas expression of REULDRING detectably increased
NDV-eGFP replication. We noted that combined expression of
RIG-I and REUL had the strongest effect on suppression of
NDV–eGFP replication, and this effection was comparable to
overexpression of VISA (Fig. 4J). Using plaque assays, we also
found that, cotransfection of REUL efficiently enhanced the
inhibitory effect on vesicular stomatitis virus (VSV) replication
mediated by overexpression of RIG-I (Fig. 4K), whereas
knockdown of REUL had the opposite effect, increasing viral
replication as potently as VISA RNAi (Fig. 4L).
Collectively, these data suggest that REUL plays a critical role
in the efficient cellular antiviral response mediated by RIG-I.
REUL is an E3 ubiquitin ligase of RIG-I
Previously, it has been reported that RIG-I undergoes robust
ubiquitination at its N-terminal 2CARD, and RIG-I ubiquitina-
tion is induced by the TRIM family member TRIM25 in
mammalian cells [15]. As the RING domain of REUL is required
for potentiation of RIG-I-mediated signaling, we predicted that
REUL is a novel E3 ubiquitin ligase of RIG-I. To test the role of
REUL in RIG-I ubiquitination, RIG-I was co-expressed with
wild-type REUL or the E3 ligase-defective REULDRING (Aa 91–
432) mutant together with ubiquitin. We found that RIG-I was
extensively ubiquitinated and REUL expression markedly in-
creased the ubiquitination levels of RIG-I. In contrast, REULDR-
ING efficiently decreased RIG-I ubiquitination levels (Fig. 5A). To
exclude that Trim25 is ultimately affecting RIG-I ubiquitination,
we repeated this experiment using Trim25 RNAi and found that
in TRIM25 knock-down cells, REUL facilitated the ubiquitination
of RIG-I efficiently (Fig. 5B). Finally, in vitro ubiquitination assay
confirmed that REUL (E3), together with E1 and UbcH5b (E2),
effectively delivered the ubiquitin to RIG-I (Fig. 5C). These results
demonstrated that REUL directly affects RIG-I ubiquitination,
and the effect of REUL is independent of TRIM25.
Furthermore, we detected that SV infection treatment resulted
in the markedly increased ubiquitination of endogenously RIG-I.
Overexpression of REUL accelerated SV induced ubiquitination
of endogenously RIG-I, and REULDRING potently inhibited this
effect (Fig. 5D). These results confirmed REUL effections on
ubiquitination of endogenous RIG-I.
To demonstrated which domain of RIG-I was ubiquitinated by
REUL, HEK293T cells were co-transfected with Flag-tagged
REUL, HA-tagged full-length RIG-I, or a RIG-I mutant RIG-
IDCARD (Aa 219–925), which the 2CARD had been deleted,
together with Flag-tagged ubiquitin. REUL expression markedly
increased the ubiquitination levels of full-length RIG-I, but not
RIG-IDCARD (Fig. 5E). These data suggested that REUL
ubiquitinates the CARD domain of RIG-I.
The Lys 154, 164, and 172 residues of the RIG-I CARD
domain are critical for efficient REUL-mediated
ubiquitination and signaling activity of RIG-I
Previously, it has been reported that the Lys 172 residue in the
RIG-I CARD domain is critical for TRIM25-mediated ubiquiti-
nation and the ability of RIG-I to induce antiviral signal
transduction [15]. To further dissect the possible ubiquitination
sites of RIG-I that are critically involved in antiviral signaling, we
individually replaced the nineteen lysine residues in the RIG-I
CARD domain with arginine. In reporter gene assays, we found
that compared with wild-type RIG-I, the K154R, K164R and
K172R caused marked loss of the ability to induce activation of
IFN-b promoter. In contrast, the other KR mutations: K18, 45,
48, 59, 95, 96, 99, 108, 115, 146, 169, 177, 181, 190, 193 and
203R had little or no effect on IFN-b promoter activation (Fig. 6A).
We next tested the functions of mutants K154R, K164R,
K172R individually and in various combinations. Reporter assay
results showed that the double mutants K164/154R, K172/154R,
K172/164R, and the triple mutant K154R/K164R/K172R
caused near-complete loss of the ability to induce activation of
upper panels. The experiments were repeated twice, and similar results were obtained. (C) Endogenous interaction of REUL and RIG-I. HEK293T
(3610
6) cells were treated with SV, transfected with polyI:C (100 mg) or left untreated for 4 h before lysate. Cell lysates were immunoprecipitated (IP)
and Western blot (IB) by indicated antibodies. (D) Identification of domains of REUL mediating the interaction with RIG-I. HEK293T cells (1610
6) were
transfected with expression plasmids for HA-RIG-I alone or together with Flag-REUL or its mutants (5 mg each). Cell lysates were immunoprecipitated
with indicated antibodies. The immunoprecipitates were analyzed by Western blots with anti-HA or anti-Flag antibody. Whole-cell lysates were
analyzed by Western blots with anti-Flag and anti-HA to determine the expression levels of transfected plasmids. Upper panel: schematic
representation of REUL. (E) Identification of domains of RIG-I mediating the interaction with REUL. HEK293T cells (1610
6) were transfected with F-
REUL (left panel), F-TRIM25 (middle panel), F-TRIM5-a (right panel) alone or together with HA-RIG-I or its mutants. Immunoprecipitation and Western
blot analysis were performed with indicated antibodies.
doi:10.1371/journal.pone.0005760.g002
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PLoS ONE | www.plosone.org 5 June 2009 | Volume 4 | Issue 6 | e5760Figure 3. REUL potentiates RIG-I signaling. (A), (B), (C) REUL potentiates RIG-I-, but not MDA5-mediated activation of ISRE (A), NF-kB (B) and IFN-
b (C) promoter in a dose-dependent manner. HEK293T cells (1610
5) were transfected with the indicated reporter plasmid (50 ng), pRL-TK Renilla
luciferase plasmid (50 ng), expression plasmid for RIG-I or MDA5 (200 ng) and the indicated amounts of an expression plasmid for REUL or empty
plasmids. Luciferase assays were performed 24 h after transfection. (D) REUL potentiates RIG-I-, but not MDA5-mediated IRF3 dimerization. HEK293
cells (2610
5) were transfected with indicated plasmids. 24 h after transfection, cell lysates were separated by native PAGE and analyzed with IRF3
antibody. The experiments were repeated three times with similar results. (E) REUL potentiates RIG-I-, but not MDA5-mediated IRF3 translocation.
Novel E3/Stimulator of RIG-I
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K190R/K193R induced IFN-b promoter activity as strongly as
wild-type RIG-I (Fig. 6B). These data suggested that Lys 154, 164
and 172 are the critical sites for RIG-I signaling activity.
We also determined whether Lys 154, 164, and 172 are the key
sites for REUL-mediated ubiquitination and activity of RIG-I.
Reporter assay results showed that overexpression of REUL
potently potentiated the ability of wild-type RIG-I to activate IFN-
b promoter. But the K154R, K164R and K172R mutations
significantly reduced the activation level, and REUL almost
completely failed to induce activation of RIG signaling when
cotransfected with the double mutants K164/154R, K172/154R,
or K172/164R, or the triple mutant K154R/K164R/K172R
(Fig. 6B). In contrast, co-expression with REUL, K18R and
K190R/193R induced IFN-b activity as strongly as the wild-type.
These data indicated that Lys 154, 164, and 172 are the key sites
for the REUL-mediated signaling activity of RIG-I.
To test the role of Lys 154, 164, and 172 in RIG-I
ubiquitination mediated by REUL, wild type RIG-I and
mutations were co-expressed with or without REUL. Consistently,
with REUL expression, the ubiquitination levels of wild type RIG-
I, K18R and K190R/193R were markedly increased, whereas
those of K154R, K164R, or K172R, the double mutants K164/
154R, K172/154R, K172/164R, or the triple mutant K154R/
K164R/K172R were minimal. We also detected the similar result
without REUL expression (Fig. 6C). These data suggest that Lys
154, 164, and 172 are the primary sites for efficient REUL-
mediated ubiquitination of RIG-I.
Discussion
REUL has also been identified as Riplet in a recent publication
[20]. Riplet has been reported to promote RIG-I-mediated
interferon-b promoter activation, and inhibit propagation of a
negative-strand RNA virus (vesicular stomatitis virus). Our results
confirmed the functions of this protein. But there are several
critical differences between the findings for REUL and Riplet.
Firstly, Riplet was reported to promote lysine 63-linked poly-
ubiquitination of the C-terminal region of RIG-I, which
modification was considered by the authors to differ from the N-
terminal ubiquitination by TRIM25 [16]. But in our study, no
apparent ubiquitination level was detected in overexpression of
RIG-IDCARD (carrying helicase and RD domains) alone or
together with REUL. As a control, in the same conditions, full-
length RIG-I was extensively ubiquitinated and REUL expression
markedly increased the ubiquitination levels of RIG-I. These
results suggested that the CARD domain, but not the helicase
domain of RIG-I is ubiquitinated through REUL action.
Secondly, Riplet has been reported to bind to the C-terminal
helicase and RD regions of RIG-I, and fails to co-precipitate the
CARD domains of RIG-I [16]. In our study, the CARD and
helicase domains of RIG-I interacted with REUL individually, and
efficiently as full-length RIG-I. This result suggested that there are
multiple binding sites on RIG-I which mediate the interaction with
REUL.
Furthermore, Riplet has been reported to potentiate polyI:C-
induced activation (cells stimulated with medium containing
polyI:C) of the IFN-b promoter [16]. In our study, polyI:C did
not activate IFN-b expression in TLR3-deficient 293T cells when
applied extracellularly (data not shown). And REUL or RE-
ULDRING also had no effect on signaling induced by intracellular
(transfected) polyI:C in HEK293T cells. Previously, it has been
demonstrated that, in mouse embryonic fibroblasts, MDA5 is
involved in IFN induction triggered by polyI:C transfected into the
cytoplasm [3]. And in reporter assays, knockdown of MDA5
significantly inhibits cytoplasmic polyI:C-induced ISRE activation,
whereas knockdown of RIG-I has a minimal inhibitory effect [19],
suggesting that cytoplasmic polyI:C-induced IRF-3 activation is
mostly mediated by MDA5 in HEK293 cells. In our study, REUL
was associated with RIG-I but not MDA5 in mammalian cells
(Fig. 2). Overexpression of REUL inhibited RIG-I- but not
MDA5-mediated activation of ISRE, NF-kB and IFN-b promoter
(Fig. 3). Overexpression of REULDRING efficiently inhibited SV,
but not polyI:C-induced IFN-b promoter activation in HEK293T
cells (Fig. 4). These results confirm that REUL is specifically
involved in the RIG-I-, but not the MDA5-mediated signaling
pathway.
Another E3 ligase, Trim25, has recently been shown to induce
K63-linked ubiquitination of RIG-I and to contribute to the
activation of downstream signaling pathways [15]. TRIM25 and
REUL have homologous domain patterns and regulate RIG-I in a
similar manner. Both of them deliver ubiquitin to the CARD
domain of RIG-I. In addition, REUL interacts with RIG-I
through its C-terminal PRY and SPRY domains; this is the same
as TRIM25, which also contains a C-terminal SPRY domain. On
the other hand, the CARD domain of RIG-I has been reported to
bind TRIM25, and the interaction between the helicase domain
and TRIM25 has not been identified [15]. In our study, we found
that in the same way, REUL and TRIM25 interacted with the
helicase domain as well as the CARD domain of RIG-I. These
results suggested that there are multiple binding sites on RIG-I
which mediate the interaction with REUL and TRIM25, although
only the CARD domain is their ubiquitination target.
The Lys 172 residue of RIG-I is critical for efficient TRIM25-
mediated ubiquitination and for VISA binding [15], as well as the
ability of RIG-I to induce antiviral signal transduction. In the same
report, mutations of K99, 169, 181, 190 and 193 were
demonstrated to induce IFN-b and NF-kB promoter efficiently.
Our study confirmed these results and notably suggested that Lys
154 and Lys 164 are also critical sites for RIG signaling. The
K154R and K164R mutants disrupted the signaling function of
RIG-I to induce activation of IFN-b promoter as strongly as the
K172R mutant. Combined double or triple mutants caused near-
complete loss of the ability of RIG-I to induce activation of IFN-b
promoter. Our results showed that not only K172, but also K154
and K164 are involved in REUL-mediated RIG-I ubiquitination
and signaling.
Although TRIM25 and REUL regulate RIG-I in a similar
manner, they function independently of each other. Using Trim25
siRNA, we found that in TRIM25 knock-down cells, REUL
HEK293-RIG-I stable cell line and HEK293-MDA5 stable cell line (2610
5 cells) were transfected with indicated plasmids. 24 h after transfection,
immunofluorescent staining was performed with anti-HA antibody (red) and anti-IRF3 antibody (green). The cells expressed REUL or VISA was
counted, and the percentage of cells with nuclear IRF3 was calculated. The experiments were repeated twice, and similar results were obtained. (F)
REUL potentiates RIG-I-, but not MDA5-mediated gene expression. HEK293T cells (2610
5) were transfected with indicated plasmids. 24 h after
transfection, total RNA was isolated and RT-PCR was performed using indicated primers. (G), (H), (I) RING domain deletion mutant REULDRING
suppresses RIG-I-, but not MDA5-mediated activation of ISRE (H), NF-kB (I) and IFN-b (G) promoter in a dose-dependent manner. Transfection and
luciferase assay were performed as in (A), (B) and (C).
doi:10.1371/journal.pone.0005760.g003
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PLoS ONE | www.plosone.org 7 June 2009 | Volume 4 | Issue 6 | e5760Figure 4. REUL potentiates RIG-I antiviral activity. (A), (B), (C) RING domain deletion mutant REULDRING suppresses SV-induced activation of
ISRE (A), NF-kB (B) and IFN-b (C) promoter in a dose-dependent manner. HEK293T cells (1610
5) were transfected with the indicated reporter plasmid
(50 ng), pRL-TK Renilla luciferase plasmid (50 ng) and the indicated amounts of an expression plasmid for REULDRING or empty plasmids. 24 h after
transfection, cells were left uninfected or infected with SV for 8 h before luciferase assays were performed. (D) REULDRING has no effect on polyI:C-
induced IFN-b promoter. The transfections were done as in (A), (B) and (C). 16 h after transfection, cells were further transfected with polyI:C (4 mg) or
untransfected for 12 h before luciferase assays were performed. (E) Effects of REUL RNAi plasmids on the expression of transfected REUL. HEK293T
cells (2610
5) were transfected with expression plasmids for HA-REUL and HA-WDR34 as control (0.5 mg each), and the indicated RNAi plasmids (1 mg).
At 48 h after transfection, cell lysates were analyzed by Western blot with anti-HA and anti-GAPDH antibody. (F), (G), (H) REUL RNAi plasmids suppress
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PLoS ONE | www.plosone.org 8 June 2009 | Volume 4 | Issue 6 | e5760SV-induced activation of ISRE (F), NF-kB (G) and IFN-b (H) promoter. HEK293T cells (1610
5) were transfected with the indicated reporter plasmid
(50 ng), pRL-TK Renilla luciferase plasmid (50 ng), and the indicated REUL RNAi (1 mg). At 40 h after transfection, cells were left uninfected or infected
with SV for 8 h before luciferase assays were performed. (I) REUL RNAi suppresses RIG-I-, but not MDA5-mediated gene expression. HEK293T cells
(2610
5) were transfected with indicated plasmids. At 40 h after transfection, cells were left uninfected or infected with SV for 8 h before total RNA
was isolated and RT-PCR was performed using indicated primers. (J) REUL suppresses NDV-eGFP replication. HEK293T cells (1610
5) were transfected
with the indicated plasmids. At 20 h after transfection, cells were infected with NDV-eGFP at MOI 0.001. At 40 h after infection, virus titer and
replication were determined by plaque assay or GFP expression visualized by fluorescence microscopy. Pfu, plaque-forming unit. (K) REUL accelerates
RIG-I-mediated anti-VSV response. HEK293T cells (2610
5) were transfected with indicated plasmids (0.5 mg each). At 30 h after transfection, cells were
infected with VSV (MOI=0.001) and supernatants were harvested at 12, 18, 24 and 30 h post infection. Supernatants were analyzed for VSV
production using standard plaque assays. Plaques were counted and titers calculated as plaque-forming units (pfu/ml). (L) Knockdown of REUL
inhibits RIG-I-mediated anti-VSV response. The experiments were carried out as in (K).
doi:10.1371/journal.pone.0005760.g004
Figure 5. REUL is an E3 ubiquitin ligase of RIG-I. (A) REUL increases the ubiquitination levels of RIG-I in overexpression system. HEK293T cells
were transfected with indicated REUL, REULDRING, RIG-I or ubiquitin plasmids. Cell lysates were immunoprecipitated (IP) with anti-HA (aHA). The
immunoprecipitates were analyzed by Western blot (IB) with anti-Flag antibody (aF). Whole-cell lysates were analyzed by Western blots with anti-HA
or anti-Flag to determine the expression of REUL, REULDRING and RIG-I. (B) REUL increases the ubiquitination levels of RIG-I in TRIM25 knock down
cells. HEK293T cells were transfected with TRIM25 RNAi and indicated RIG-I, REUL and REULDRING plasmids. 48 h after transfection, cells were lysated.
Immunoprecipitation and western blot were performed as in (A). (C) REUL delivered ubiquitin to RIG-I in vitro. In vitro expressed REUL and RIG-I were
used to ubiquitination assay, Biotinylated ubiquitin was detected by HRP-streptavidin. (D) REUL effects on ubiquitination of endogenous RIG-I.
HEK293T cells transfected with indicated REUL, REULDRING, and ubiquitin plasmids. 24 h after transfection, cells were left uninfected or infected with
SV for 24 h before lysate. Immunoprecipitation and Western blot were performed as in (A) except that anti-RIG-I antibody (aRIG-I) were used to
detect endogenous RIG-I. (E) REUL does not increase the ubiquitination levels of RIG-I DCARD. HEK293T cells transfected with indicated REUL, RIG-I,
RIG-I DCARD and ubiquitin plasmids. Cell lysates were immunoprecipitated with anti-HA (aHA). The immunoprecipitates were analyzed by Western
blot with anti-Flag antibody (aF). Whole-cell lysates were analyzed by Western blot with anti-HA or anti-Flag to determine the expression of REUL,
RIG-I and RIG-IDCARD.
doi:10.1371/journal.pone.0005760.g005
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PLoS ONE | www.plosone.org 9 June 2009 | Volume 4 | Issue 6 | e5760Figure 6. Lys 154, 164, 172 are the essential sites for RIG-I and REUL signaling. (A) K154R, K164R and K172R are the essential sites for RIG-I
induced activation of IFN-b promoter. HEK293T cells (1610
5) were transfected with IFN-b promoter reporter plasmid (50 ng), pRL-TK Renilla luciferase
plasmid (50 ng), and the indicated expression plasmids of RIG-I wild type (WT) and mutations. Reporter assays were performed 24 h after
transfection. Lower panel: expression of RIG-I wild type (WT) and mutations. (B) K154R, K164R and K172R are the essential sites for REUL effect.
Transfection and luciferase assay were performed as in (A), except cotransfection with REUL. (C) K154R, K164R and K172R are the essential sites for
REUL-mediated RIG-I ubiquitination. HEK293T cells were transfected with indicated expression plasmids of RIG-I wild type, mutations and ubiquitin,
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ubiquitin assays showed that REUL directly delivered ubiquitin to
RIG-I. These results demonstrated that the function of REUL is
independent of TRIM25. TRIM25 and REUL are not ubiqui-
tously distributed over the organs tested. Northern blots showed
that human Riplet is expressed in human skeletal muscle, spleen,
kidney, placenta, prostate, stomach, thyroid and tongue, and
weakly expressed in heart, thymus, liver, lung and uterus [16].
Whereas TRIM25/Efp is predominantly expressed in various
female organs such as the uterus, ovary, mammary gland and
placenta [20]. Since TRIM25 and REUL have different
distribution patterns, we suggest that REUL may be a complement
factor of TRIM25 for RIG-I activation.
We noted that expression of the mutant with the RING domain
deleted, REULDRING, markedly suppressed RIG-I-mediated
and SV-induced ISRE, NF-kB and IFN-b promoter, and also
efficiently inhibited NDV replication and RIG-I ubiquitination.
These data indicate that, as a dominant negative mutant,
REULDRING competes with endogenous REUL to bind with
and ubiquitinate RIG-I, and block RIG-I signaling.
As a cytosolic receptor, RIG-I activity is tightly regulated by
several mechanisms. LGP2, a RNA helicase protein lacking
CARD domains at its N terminus, acts as a negative regulator by
sequestering viral RNA from RIG-I [21,22]. CYLD targets RIG-I
for deubiquitination that leads to inactivation of the signaling
[23,24]. The autophagic protein conjugate Atg5-Atg12 negatively
regulates the type I IFN production pathway by direct association
with the CARD domain of RIG-I [25]. ISG15 has been reported
to modify RIG-I and act as a negative feedback regulator [26].
Two RING finger proteins, RNF125 and TRIM25, have been
shown to play critical roles in regulating RIG-I activity as E3
ubiquitin ligase. RNF125-mediated K48-linked polyubiquitination
leads to the degradation of RIG-I [13], and TRIM25-mediated
K63-linked polyubiquitination activates RIG-I [15]. In the present
work, we identified REUL as a novel RIG-I E3 ubiquitin ligase
that specifically potentiates RIG-I-mediated antiviral activity. This
finding extends the regulator family of RIG-I, and the mechanisms
underlying this finding deserve further study, especially using
knockout techniques.
Materials and Methods
Reagents and cell lines
Mouse monoclonal antibodies against Flag and HA epitopes
(Sigma, USA), poly(I:C) (InvivoGen, USA), IRDye800-conjugated
anti-mouse and anti-rabbit IgG (Rockland Immunochemicals,
USA), mouse monoclonal antibody to RIG-I (Alexis Biochemicals,
Switzerland), rabbit polyclonal antibodies against IRF3 (SC-9082),
SV (Hong-Bing Shu, Wuhan University, Wuhan, China), NDV-
eGFP (Cheng Wang, Institute of Biochemistry and Cell Biology,
Shanghai, China) and VSV (Hong-Kui Deng, Peking University,
Beijing, China) were obtained from the indicated sources. Mouse
anti-REUL antibody was prepared with recombinant protein by
Experimental Animal Center, Institute of Genetics and Develop-
mental Biology, Chinese Academy of Sciences. HEK293, BHK21,
HT1080, Hela, HUVEC and U937 cells were grown in DMEM
supplemented with 10% fetal bovine serum. K562 cells were
grown in IMDM supplemented with 10% fetal bovine serum.
Yeast Two-Hybrid Screens
The human fetal kidney cDNA library (Clontech, USA) was
screened with full-length RIG-I as bait, following protocols
recommended by the manufacturer.
Constructs
Mammalian expression plasmids for Flag- or HA-tagged
TRIM25, TRIM-5a, RIG-I, REUL, and their deletion mutants
were constructed by standard molecular biology techniques.
Mammalian expression plasmids for Flag-VISA, Flag-MDA5,
Flag-Ub, and ISRE, NF-kB, and IFN-b promoter luciferase
reporter plasmids were kindly provided by Dr. Hong-Bing Shu
(Wuhan University, Wuhan, China).
Transfection and Luciferase Assays
HEK293T cells were seeded on 24-well dishes and transfected
the next day by standard calcium phosphate precipitation. In the
same experiment, we added empty control plasmid to ensure that
each transfection received the same amount of total DNA. To
normalize for transfection efficiency, 0.05 mg of pRL-TK (Renilla
luciferase) reporter plasmid was added to each transfection.
Luciferase assays were performed using a dual-specific luciferase
assay kit (Promega, USA). Firefly luciferase activity was normal-
ized based on Renilla luciferase activity. All reporter assays were
repeated at least three times. Data shown are average values 6SD
from one representative experiment.
Coimmunoprecipitation and Western Blot Analysis
For transient transfection and immunoprecipitation experi-
ments, HEK293T cells (,2610
5) were transfected with the
indicated plasmids for 20 h. The transfected cells were lysed in
0.5 ml of lysis buffer (20 mM Tris, pH 7.5, 150 mM NaCl, 1%
Triton X-100, 1 mM EDTA, 10 mg/ml aprotinin, 10 mg/ml
leupeptin, 1 mM phenylmethylsulfonyl fluoride). For each immu-
noprecipitation, a 0.4 ml aliquot of lysate was incubated with
0.5 mg of the indicated antibody and 25 ml of a 1:1 slurry of
protein-A sepharose (GE Healthcare, USA) for 2 h. The sepharose
beads were washed three times with 1 ml of lysis buffer. The
precipitates were analyzed by Western blot with the indicated
antibodies and visualized by incubation with IRDye800-conjugat-
ed secondary antibodies (diluted 1:10,000) using an Odyssey
infrared imaging system (LICOR Inc., Germany).
Native PAGE
Native PAGE (8%) was pre-run for 30 min at 40 mA with
native running buffer (25 mM Tris and 192 mM glycine, pH 8.4)
and with 0.5% deoxycholate in the cathode chamber. Samples
were prepared in the native sample buffer (62.5 mM Tris–HCl,
pH 6.8, 15% glycerol and 0.5% deoxycholate).
Immunofluorescent staining
Cells were fixed with ice-cold methanol for 10 min at 220uC,
rehydrated three times with PBS, and blocked in 5% bovine serum
albumin/PBS for 10 min. The cells were stained with primary
antibody in blocking buffer for 1 h at 37uC, rinsed with PBS, and
stained again with FITC-conjugated Affinipure rabbit anti-mouse
IgG or Texas Red-conjugated Affinipure goat anti-rabbit IgG
together with or without REUL expression plasmid. Cell lysates were immunoprecipitated with anti-HA (aHA). The immunoprecipitates (IP) were
analyzed by Western blot (IB) with anti-Flag antibody (aF). Whole-cell lysates (WCL) were analyzed by Western blots with anti-HA or anti-Flag to
determine the expression of REUL, RIG-I wild type and mutations.
doi:10.1371/journal.pone.0005760.g006
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PBS containing DAPI and mounted in Prolong Antifade
(Molecular Probes). The cells were observed under an Olympus
BX51 immunofluorescence microscope using a 6100 plan
objective.
In vitro Ubiquitinlation Assay
In vitro protein expression was performed using TNTH quick
coupled transcription/translation systems (Promega, USA), Ubi-
quitinlation Assay was performed using ubiquitinylation kit
(ENZO life sciences, USA), Following protocols recommended
by the manufacturer.
RNAi Experiments
Double-strand oligonucleotides corresponding to the target
sequences were cloned into the pSuper.retro RNAi plasmid
(Oligoengine, USA). In this study, the target sequences for human
REUL cDNA were 1#:5 9AACATCTTGTAGACATTGTCA
39;2 #:5 9AATCAGAGATATTCTCCATGA 39;3 #:59AAGTG-
AAGTGGACACTAGGAATTGCA 39; positive control VISA
RNAi target sequence 59GTATATCTGCCGCAATTTC 39.
RT-PCR
Total RNA was isolated from HEK293T cells by using TRIzol
r e a g e n t( T i a n w e iC o . ,B e i j i n g ,C h i n a )a n ds u b j e c t e dt oR T - P C R
analysis to measure expression of IFN-b, ISG15, RANTES, TNFa
and b-actin. The gene-specific primer sequences were: IFN-b, sense:
59-CCAACAAGTGTCTCCTCCAA-39,a n t i se n s e :5 9-ATAGTCT-
CATTCCAGCCAGT-39; ISG15, sense: 59-GCTGGGACCT-
GACGGTGAAGA-39,a n t i - s e n s e :5 9-GCTCAGAGGTTCGTCG-
CATTTGT-39;R A N T E S ,s e n s e :5 9-CCTCGCTGTCATCC-
TCATTG-39, anti-sense: 59-TACTCCCGAACCCATTTCTT-39;
TNFa,s e n s e :5 9-CCTGGTATGAGCCCATCTATC-39,a n t i s e n s e :
59-CGAAGTGGTGGTCTTGTTGC-39; b- A c t i n ,s e n s e :5 9-
ACGTGGACATCCGCAAAGAC-39,a n t i s e n s e : 5 9-CAAGAAAG-
GGTGTAACGCAACTA-39.
VSV plaque assay
HEK293T cells (,1610
5) were transfected with the indicated
plasmids for 24 h prior to VSV infection. At 1 h post-infection,
cells were washed with PBS and then fresh medium was added.
The supernatant was harvested at the indicated times and used to
infect confluent BHK21 cells cultured on 24-well plates. At 1 h
post-infection, supernatant was removed and culture medium
containing 2% methylcellulose was overlaid. At 60 h post-
infection, the overlaid medium was removed; cells were fixed
with 0.5% glutaraldehyde for 30 min and stained with 1% crystal
violet dissolved in 70% ethanol. Plaques were counted, averaged
and multiplied by the dilution factor to determine viral titer as
Pfu/ml. The experiments were repeated three times and each
experiment was performed in duplicate. Data shown are average
values 6S.D. from one representative experiment.
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